Establishment of a clinical network for children with amelogenesis imperfecta and dentinogenesis imperfecta in the UK: 4-year experience.

Amelogenesis imperfecta Clinical excellence group Dentinogenesis imperfecta Genetic testing Peer support

Journal

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
ISSN: 1996-9805
Titre abrégé: Eur Arch Paediatr Dent
Pays: England
ID NLM: 101277157

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 05 10 2023
accepted: 13 12 2023
medline: 18 3 2024
pubmed: 3 2 2024
entrez: 3 2 2024
Statut: ppublish

Résumé

Amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) are two groups of genetically inherited conditions resulting in abnormal enamel and dentin formation, respectively. Children and young people may be adversely affected by these conditions, with significant reduction in oral health related quality of life. Dental management of children with AI and DI is often complex, which is exacerbated by the absence of clear referral pathways and scarce evidence-based guidelines. The need for increased knowledge and peer support led to the development of a group of UK paediatric dentists with a special clinical interest in the management of children with AI and DI. The aims of this paper are to describe the establishment of an AI/DI Clinical Excellence Network (AI/DI CEN) in paediatric dentistry including outputs and future plans, and to share our collective learning to help support others anywhere in the world advance the care of people with AI or DI.

Sections du résumé

BACKGROUND BACKGROUND
Amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) are two groups of genetically inherited conditions resulting in abnormal enamel and dentin formation, respectively. Children and young people may be adversely affected by these conditions, with significant reduction in oral health related quality of life. Dental management of children with AI and DI is often complex, which is exacerbated by the absence of clear referral pathways and scarce evidence-based guidelines.
METHOD METHODS
The need for increased knowledge and peer support led to the development of a group of UK paediatric dentists with a special clinical interest in the management of children with AI and DI.
PURPOSE OBJECTIVE
The aims of this paper are to describe the establishment of an AI/DI Clinical Excellence Network (AI/DI CEN) in paediatric dentistry including outputs and future plans, and to share our collective learning to help support others anywhere in the world advance the care of people with AI or DI.

Identifiants

pubmed: 38308725
doi: 10.1007/s40368-023-00859-2
pii: 10.1007/s40368-023-00859-2
pmc: PMC10943134
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-91

Informations de copyright

© 2024. The Author(s).

Références

Eur J Hum Genet. 2015 Apr;23(4):445-51
pubmed: 25118030
Front Pediatr. 2022 Feb 24;10:836708
pubmed: 35281236
Health Qual Life Outcomes. 2015 Dec 10;13:197
pubmed: 26651486
Br Dent J. 2021 Sep 6;:
pubmed: 34489543
Br Dent J. 2018 Aug 24;225(4):335-339
pubmed: 30141472
Int J Paediatr Dent. 2014 Sep;24(5):326-35
pubmed: 24283507
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD007157
pubmed: 23744349
J Oral Pathol. 1988 Nov;17(9-10):547-53
pubmed: 3150442
Genes (Basel). 2023 Feb 22;14(3):
pubmed: 36980818
PLoS One. 2016 Jun 30;11(6):e0156879
pubmed: 27359125
J Oral Maxillofac Surg. 2022 Oct;80(10):1686-1690
pubmed: 35931181
Front Physiol. 2017 Jun 26;8:435
pubmed: 28694781
Eur Arch Paediatr Dent. 2021 Oct;22(5):929-936
pubmed: 34146252
Eur Arch Paediatr Dent. 2022 Aug;23(4):579-586
pubmed: 35713847
J Dent Res. 2015 Aug;94(8):1041-7
pubmed: 25924855

Auteurs

J Monteiro (J)

Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK. joana.monteiro@nhs.net.

R Balmer (R)

School of Dentistry, The University of Leeds, Leeds, UK.

F Lafferty (F)

Glasgow Dental Hospital, Glasgow, UK.

A Lyne (A)

RNENTEDH, University College London Hospitals, London, UK.

A Mighell (A)

School of Dentistry, The University of Leeds, Leeds, UK.

K O'Donnell (K)

Leeds Dental Hospital, Leeds, UK.

S Parekh (S)

UCL Eastman Dental Institute, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH